Publications by authors named "Kelly Cozens"

Claim this Profile
I
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.
Emanuele Zucca, Luca Ceriani, Giovannino Ciccone, Alice Di Rocco, Maria Cristina Pirosa, Kelly Cozens

Blood· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ELECTRA Trial: Approach to Contemporary Challenges in the Development and Implementation of Double-Blinded, Randomised, Controlled Clinical Trials in Low-Volume High-Complexity Surgical Oncology.
Sean Ewings, Nadia Peppa, Daniel Griffiths, Maria Hawkins, Claire Birch, Kelly Cozens

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the variation of modern endoscopic ultrasound use in patients with oesophageal cancer (VALUE): protocol for a multi-methods study.
Kieran G Foley, Cherish Boxall, James Franklin, Andrew Cook, Tim Underwood, Kelly Cozens

BJR Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules.
Fiona J Gilbert, Scott Harris, Kenneth A Miles, Jonathan R Weir-McCall, Nagmi R Qureshi, Kelly Cozens

Thorax· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELEVATE - evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial.
Elizabeth Smyth, Kelly Cozens, Daniel Griffiths, Kathryn L Clark, Sean Ewings

BMC Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, Christopher P Fox, Elisabeth Schorb, Kelly Cozens

Leukemia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling.
Fiona J Gilbert, Scott Harris, Kenneth A Miles, Jonathan R Weir-McCall, Nagmi R Qureshi, Kelly Cozens

Health Technol Assess· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial.
Andrés J M Ferreri, Jeanette K Doorduijn, Alessandro Re, Maria Giuseppina Cabras, Jeffery Smith, Kelly Cozens

Lancet Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer.
Hayley S McKenzie, Graham Mead, Robert Huddart, Jeff D White, Gordon J S Rustin, Kelly Cozens

Clin Genitourin Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma.
Luca Ceriani, Lisa Milan, Maurizio Martelli, Andrés J M Ferreri, Luciano Cascione, Kelly Cozens

Blood· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial.
Dean A Fennell, Emma Kirkpatrick, Kelly Cozens, Mavis Nye, Jason Lester

Trials· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study.
Tim M Illidge, Hayley S McKenzie, Sam Mayes, Andrew Bates, Andrew J Davies, Kelly Cozens

Br J Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis